Tìm theo
Reglixane
Các tên gọi khác (1) :
  • JTT-501
Thuốc Gốc
Small Molecule
Reglixane, an isoxazolidine-3,5-dione derivative, is being developed by Pfizer for the treatment of diabetes. It is the first non-thiazolidenedione to enter clinical trials.
Dược Lực Học : Reglixane shows a hypoglycemic effect and also a stronger triglyceride-lowering effect than the thiazolidine-2,4-diones. In preclinical studies, reglixane has been shown to prevent several diabetic complications, such as cataract, nephropathy, and neuropathy.
Cơ Chế Tác Dụng : Reglixane, an isoxazolidine-3,5-dione derivative, is being developed by Pfizer for the treatment of diabetes. It is the first non-thiazolidenedione to enter clinical trials. Reglixane is an agonist of peroxisome proliferator-activated receptor (PPAR) gamma and alpha.
Chỉ Định : For the treatment of diabetes mellitus type 1 and 2.
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB04971
... loading
... loading